1-3 of 3
Rose Villarreal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bortezomib, Dexamethasone and Rituximab (BDR) Is a Highly Active Regimen in the Primary Therapy of Waldenstrom’s Macroglobulinemia: Planned Interim Results of WMCTG Clinical Trial 05-180.

Steven P. Treon, MD, PhD, Jacob D. Soumerai, Christopher J. Patterson, Zachary R. Hunter, Irene M. Ghobrial, MD, Rose Villarreal, MS,PA-C, Michael A. Willen, MD, Thomas J. Myers, MD
Journal: Blood
Blood (2006) 108 (11): 2765.
https://doi.org/10.1182/blood.V108.11.2765.2765
Published: 2006
Journal Articles

Analysis of Chemokine and Adhesion Markers in Waldenstrom Macroglobulinemia.

Hai T. Ngo, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Evdoxia Hatjiharissi, MD, Xiaoying Jia, Garrett O’Sullivan, Judith Runnels, PhD, Rose Villarreal, Zachary Hunter, Steven Treon, MD,PhD, Teru Hideshima, MD, Kenneth Anderson, MD, Irene Ghobrial, MD
Journal: Blood
Blood (2006) 108 (11): 4653.
https://doi.org/10.1182/blood.V108.11.4653.4653
Published: 2006
Journal Articles

Imatinib Mesylate (Gleevec®) Is Active in Relapsed/Refractory Waldenstrom’s Macroglobulinemia: Planned Interim Results of WMCTG Clinical Trial 05-140.

Steven P. Treon, MD, PhD, Jacob D. Soumerai, Christopher J. Patterson, Zachary R. Hunter, Rose Villarreal, MS, PA-C, Irene M. Ghobrial, MD
Journal: Blood
Blood (2006) 108 (11): 2484.
https://doi.org/10.1182/blood.V108.11.2484.2484
Published: 2006